These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33163050)

  • 1. Elabela levels in patients with type 2 diabetes: can it be a marker for diabetic nephropathy?
    Onalan E; Doğan Y; Onalan E; Gozel N; Buran I; Donder E
    Afr Health Sci; 2020 Jun; 20(2):833-840. PubMed ID: 33163050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Elabela/Toddler Levels Are Associated with Albuminuria in Patients with Type 2 Diabetes.
    Zhang H; Gong D; Ni L; Shi L; Xu W; Shi M; Chen J; Ai Y; Zhang X
    Cell Physiol Biochem; 2018; 48(3):1347-1354. PubMed ID: 30048993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy.
    Emara AM; El Bendary AS; Ahmed LM; Okda HI
    BMC Nephrol; 2024 Jul; 25(1):231. PubMed ID: 39030467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
    Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
    Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocan and albuminuria in type 2 diabetes mellitus.
    Cikrikcioglu MA; Erturk Z; Kilic E; Celik K; Ekinci I; Yasin Cetin AI; Ozkan T; Cetin G; Dae SA; Kazancioglu R; Erkoc R
    Ren Fail; 2016 Nov; 38(10):1647-1653. PubMed ID: 27756187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum elabela and apelin levels during different stages of chronic kidney disease.
    Lu X; Liu S; Luan R; Cui W; Chen Y; Zhang Y; Lu Y; Zhang H; Shi L; Miao L; Xu F
    Ren Fail; 2020 Nov; 42(1):667-672. PubMed ID: 32713238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
    Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
    Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Matrix Metalloproteinase-3 Activity and Glomerular Filtration Rate and Albuminuria Status in Patients With Type 2 Diabetes Mellitus.
    Amanzadeh M; Mota A; Zarghami N; Abedi-Azar S; Abroon S; Akbarian N; Mihanfar A; Rahmati-Yamchi M
    Iran J Kidney Dis; 2018 Jan; 12(1):40-47. PubMed ID: 29421776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
    Tan SMQ; Chiew Y; Ahmad B; Kadir KA
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
    Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
    Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum myeloid-related protein 8/14 is a potential predictor of diabetic kidney disease.
    Gu W; Cui J; Shi M; Zhang R; Tan D; Zhang X; Zhang H
    Discov Med; 2020; 30(160):97-105. PubMed ID: 33382965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
    Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
    J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study.
    Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y
    Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 is independently associated with progression of nephropathy in type 2 diabetes mellitus.
    Tan KCB; Cheung CL; Lee ACH; Lam JKY; Wong Y; Shiu SWM
    Diabetologia; 2018 May; 61(5):1212-1219. PubMed ID: 29417184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
    Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
    J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
    Shiju TM; Mohan V; Balasubramanyam M; Viswanathan P
    J Diabetes Complications; 2015 Apr; 29(3):400-6. PubMed ID: 25619588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
    Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
    Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Profile of Plasma Free Amino Acids in Type 2 Diabetes Mellitus with Insulin Resistance: Association with Microalbuminuria and Macroalbuminuria.
    Saleem T; Dahpy M; Ezzat G; Abdelrahman G; Abdel-Aziz E; Farghaly R
    Appl Biochem Biotechnol; 2019 Jul; 188(3):854-867. PubMed ID: 30706418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.